Table 3. Demographic and clinical data of patients with pathogens detected in the nasopharyngeal clinical sample during the outbreak in the Indigenous Guarani village of Paraty Mirim, Rio de Janeiro–Brazil, 2016.
| PN* | Age | Sex | Vaccination TIV* (Days) | Case classification |
Collection date (Days for the onset symptoms) |
Pathogens detected by real time RT-PCR | Treatment† | Clinical outcome |
|---|---|---|---|---|---|---|---|---|
| 1 | 60.7 | M | Yes (328) | ARI* | Ignored | hRSV* | 1 | R* |
| 2 | 5.8 | M | Yes (326) | ILI* | Apr 8, 2016 (6) | FLU* | 2 | R |
| 3 | 2.4 | M | Yes (330) | SARI-NH* | Apr 8, 2016 (2) | FLU/hRSV | 3 | R |
| 4 | 2.3 | M | Yes (326) | SARI-NH | Apr 8, 2016 (6) | FLU/hRSV | 3 | R |
| 5 | 2.3 | M | Yes (230) | SARI-NH | Apr 6, 2016 (4) | FLU | 2 | R |
| 6 | 1.6 | M | Yes (266) | SARI-NH | Apr 8, 2016 (6) | hRSV | 2 | R |
| 7 | 1.3 | F | Yes (294) | ILI | Apr 8, 2016 (6) | hRSV | 2 | R |
| 8 | 1.3 | F | Yes (266) | SARI | Ignored | FLU | 3 | HR* |
| 9 | 1.2 | F | Yes (266) | SARI | Apr 4, 2016 (2) | FLU/hRSV | 3 | HD* |
| 10 | 1.1 | F | Yes (195) | SARI-NH | Apr 8, 2016 (6) | FLU/hRSV | 3 | R |
| 11 | 9m* | M | Yes (62) | ILI | April 8, 2016 (5) | FLU | 3 | R |
| 12 | 9m* | F | Yes (65) | SARI | April 8, 2016 (6) | FLU | 3 | HR |
| 13 | 4m* | F | NA* | SARI | April 8, 2016 (6) | hRSV | 3 | HR |
| 14 | 1m* | F | NA* | SARI | Apr 6, 2016 (4) | FLU/hRSV | 3 | HR |
*PN–Patient number, m–age in months, TIV–trivalent influenza vaccine, NA—Non-applied (under minimum age for vaccination), ARI—acute respiratory illness non-influenza-like illness and non-severe acute respiratory infection, ILI–influenza-like illness, SARI—severe acute respiratory infection, SARI-NH—signs and symptoms of SARI, non-hospitalized, FLU—Influenza A(H1N1)pdm09, hRSV–human Respiratory Syncytial Virus, R–recovered; HR–hospitalized and recovered; HD–hospitalized and death.
†1—symptomatic, 2—antibiotic + symptomatic, 3—antibiotic + symptomatic + oseltamivir.